Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NF2”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT02831257
What this trial is testing

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Who this might be right for
Neurofibromatosis 2Meningioma
Massachusetts General Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01767792
What this trial is testing

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Who this might be right for
Neurofibromatosis Type 2Progressive Vestibular Schwannomas
University of Alabama at Birmingham 22
Testing effectiveness (Phase 2)Looking for participantsNCT06553365
What this trial is testing

Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors

Who this might be right for
Nerve Sheath Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05521048
What this trial is testing

Doxycycline in Cutaneous Schwannoma (NF2)

Who this might be right for
Neurofibromatosis Type 2
Massachusetts Eye and Ear Infirmary 19
Testing effectiveness (Phase 2)Ended earlyNCT01345136
What this trial is testing

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Who this might be right for
Neurofibromatosis Type 2Neuroma, Acoustic
Jonsson Comprehensive Cancer Center 4
Very early researchStudy completedNCT00863122
What this trial is testing

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Who this might be right for
Vestibular SchwannomaNF2Neurofibromatosis 2+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Study completedNCT02104323
What this trial is testing

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Beijing Tiantan Hospital 20
Not applicableLooking for participantsNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableUnknownNCT03893643
What this trial is testing

Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15

Who this might be right for
Neurofibromatosis 2Dermatology/Skin - Other
Centre Hospitalier Universitaire de Nice 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04374305
What this trial is testing

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more
Scott R. Plotkin, MD, PhD 100
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Not applicableUnknownNCT00004483
What this trial is testing

NF2 Natural History Consortium

Who this might be right for
Schwannoma, VestibularNeurofibromatosis 2Meningioma
House Ear Institute 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439331
What this trial is testing

Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Very early researchStudy completedNCT01880749
What this trial is testing

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomasMeningiomas
NYU Langone Health 5
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Not applicableActive Not RecruitingNCT03873610
What this trial is testing

Resiliency Training in Adolescents With NF1 and NF2

Who this might be right for
Neurofibromatoses
Massachusetts General Hospital 200
Not applicableStudy completedNCT03210285
What this trial is testing

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaAcoustic Neuroma
University Hospital Tuebingen 70
Load More Results